ILAE Genetics Literacy series: Progressive myoclonus epilepsies.


Journal

Epileptic disorders : international epilepsy journal with videotape
ISSN: 1950-6945
Titre abrégé: Epileptic Disord
Pays: United States
ID NLM: 100891853

Informations de publication

Date de publication:
Oct 2023
Historique:
revised: 21 07 2023
received: 24 04 2023
accepted: 19 08 2023
medline: 7 3 2024
pubmed: 24 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

Progressive Myoclonus Epilepsy (PME) is a rare epilepsy syndrome characterized by the development of progressively worsening myoclonus, ataxia, and seizures. A molecular diagnosis can now be established in approximately 80% of individuals with PME. Almost fifty genetic causes of PME have now been established, although some remain extremely rare. Herein, we provide a review of clinical phenotypes and genotypes of the more commonly encountered PMEs. Using an illustrative case example, we describe appropriate clinical investigation and therapeutic strategies to guide the management of this often relentlessly progressive and devastating epilepsy syndrome. This manuscript in the Genetic Literacy series maps to Learning Objective 1.2 of the ILAE Curriculum for Epileptology (Epileptic Disord. 2019;21:129).

Identifiants

pubmed: 37616028
doi: 10.1002/epd2.20152
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

670-680

Subventions

Organisme : NINDS NIH HHS
ID : K23NS121520
Pays : United States

Investigateurs

Piero Perucca (P)
J Helen Cross (JH)
Holger Lerche (H)
Alina I Esterhuizen (AI)
Iscia Lopes-Cendes (I)
Meng-Han Tsai (MH)
Daniel H Lowenstein (DH)
Nigel C K Tan (NCK)
Ingo Helbig (I)
Heather C Mefford (HC)
Andreas Brunklaus (A)
Gaetan Lesca (G)
Elizabeth Emma Palmer (EE)
Amy McTague (A)
Faiza Fakhfakh (F)
Norman Delanty (N)
Daniel H Lowenstein (DH)
Nigel C K Tan (NCK)
Alina I Esterhuizen (AI)

Informations de copyright

© 2023 The Authors. Epileptic Disorders published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Références

Epilepsia. 2023 May;64(5):1368-1375
pubmed: 36808730
Hum Mol Genet. 2019 Dec 1;28(23):3867-3879
pubmed: 31807779
Orphanet J Rare Dis. 2019 Jun 21;14(1):149
pubmed: 31227012
N Engl J Med. 2019 Oct 24;381(17):1644-1652
pubmed: 31597037
Nat Neurosci. 2007 Nov;10(11):1407-13
pubmed: 17952067
Neurology. 2013 May 28;80(22):2049-54
pubmed: 23635963
Mol Genet Metab. 2016 Sep;119(1-2):160-7
pubmed: 27553878
J Neurol. 2016 May;263(5):961-972
pubmed: 26995359
Ann Neurol. 1990 Jul;28(1):113-6
pubmed: 2115761
Epilepsy Res. 2006 May;69(2):129-34
pubmed: 16504479
Mol Ther. 2017 Aug 2;25(8):1889-1899
pubmed: 28506594
Orphanet J Rare Dis. 2017 Mar 7;12(1):45
pubmed: 28264719
Epileptic Disord. 2016 Sep 1;18(S2):38-62
pubmed: 27702709
Epilepsia. 2005 Oct;46(10):1695-7
pubmed: 16190947
J Neurol Sci. 2007 Jan 15;252(1):16-23
pubmed: 17166519
Nat Genet. 1995 May;10(1):47-55
pubmed: 7647790
Epilepsia. 2008 Apr;49(4):557-63
pubmed: 18028412
Rev Neurol (Paris). 1983;139(2):115-24
pubmed: 6410486
Neurol Genet. 2021 Nov 12;7(6):e641
pubmed: 34786481
Neurology. 2004 Aug 10;63(3):565-7
pubmed: 15304597
Epilepsia. 2012 Dec;53(12):2120-7
pubmed: 23205931
Epileptic Disord. 2019 Apr 1;21(2):129-140
pubmed: 30892268
Seizure. 2019 Oct;71:247-257
pubmed: 31476531
Neurology. 2015 Apr 14;84(15):1529-36
pubmed: 25770194
Pract Neurol. 2015 Jun;15(3):164-71
pubmed: 25720773
Nature. 1997 Apr 24;386(6627):847-51
pubmed: 9126745
Cerebellum Ataxias. 2014 Sep 01;1:11
pubmed: 26331035
N Engl J Med. 2018 May 17;378(20):1898-1907
pubmed: 29688815
Epilepsy Behav. 2009 Mar;14(3):545-9
pubmed: 19185615
Int J Biochem Cell Biol. 2015 Dec;69:204-14
pubmed: 26546463
Am J Hum Genet. 2012 Jul 13;91(1):202-8
pubmed: 22748208
Lancet Neurol. 2019 Jan;18(1):107-116
pubmed: 30470609
Orphanet J Rare Dis. 2021 Aug 16;16(1):362
pubmed: 34399803
J Neurobiol. 1998 Oct;37(1):69-79
pubmed: 9777733
Epileptic Disord. 2023 Oct;25(5):670-680
pubmed: 37616028
Epilepsia. 1999;40 Suppl 4:50-8
pubmed: 10487174
Epileptic Disord. 2016 Sep 1;18(S2):28-37
pubmed: 27582036
J Neurosci. 2014 Sep 24;34(39):13077-82
pubmed: 25253854
Epilepsia. 2006 May;47(5):860-6
pubmed: 16686650
Am J Hum Genet. 2021 Apr 1;108(4):722-738
pubmed: 33798445
Neurology. 2005 Mar 22;64(6):982-6
pubmed: 15781812
Neurodegener Dis. 2011;8(6):515-22
pubmed: 21757863
Mov Disord. 2018 Aug;33(8):1281-1286
pubmed: 30145808
Epileptic Disord. 2016 Sep 1;18(S2):73-88
pubmed: 27629553
Nat Genet. 1997 Mar;15(3):298-302
pubmed: 9054946
Epilepsia. 2011 Dec;52(12):2356-63
pubmed: 22050460
J Med Genet. 2012 Jun;49(6):391-9
pubmed: 22693283
Nat Genet. 2015 Jan;47(1):39-46
pubmed: 25401298
Epilepsia. 2010 Apr;51(4):676-85
pubmed: 20196795
Brain. 1988 Feb;111 ( Pt 1):27-62
pubmed: 3284607
Genes (Basel). 2018 Sep 11;9(9):
pubmed: 30208654
Neuroreport. 2017 Mar 22;28(5):268-271
pubmed: 28181916
Mol Neurobiol. 2016 Mar;53(2):1296-1309
pubmed: 25627694
Epilepsia. 2015 May;56(5):692-8
pubmed: 25847462
Nat Genet. 1998 Oct;20(2):171-4
pubmed: 9771710
Science. 1996 Mar 22;271(5256):1731-4
pubmed: 8596935
J Clin Neurophysiol. 2012 Apr;29(2):160-4
pubmed: 22469682
J Biol Chem. 2008 Feb 15;283(7):4069-76
pubmed: 18070875
Arch Neurol. 1982 Apr;39(4):236-8
pubmed: 6803743
Front Neurol. 2021 Mar 24;12:630366
pubmed: 33841303
Lancet Neurol. 2010 Mar;9(3):318-30
pubmed: 20170845
Ann Neurol. 1985 Apr;17(4):356-60
pubmed: 4004157
Brain. 1989 Oct;112 ( Pt 5):1261-76
pubmed: 2508989
Epilepsy Behav. 2021 Sep;122:108157
pubmed: 34171687
Nat Rev Neurol. 2018 Oct;14(10):606-617
pubmed: 30143794
Ann Neurol. 2017 May;81(5):677-689
pubmed: 28380698
BMJ Case Rep. 2014 Oct 16;2014:
pubmed: 25323282
Epilepsia. 2008 Apr;49(4):549-56
pubmed: 18325013
Neurology. 2016 Aug 9;87(6):579-84
pubmed: 27412140
Neurology. 2020 Dec 8;95(23):e3117-e3123
pubmed: 32943486
Brain. 2019 Jan 1;142(1):59-69
pubmed: 30561534
Hum Mutat. 2009 May;30(5):715-23
pubmed: 19267391
Brain. 2013 Apr;136(Pt 4):1146-54
pubmed: 23449775
Epileptic Disord. 2016 Sep 1;18(S2):11-27
pubmed: 27702708

Auteurs

Jillian M Cameron (JM)

Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, Victoria, Australia.

Colin A Ellis (CA)

Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Samuel F Berkovic (SF)

Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH